Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Mitchell P. Croatt is active.

Publication


Featured researches published by Mitchell P. Croatt.


Organic Letters | 2011

Selective Formation of 1,5-Substituted Sulfonyl Triazoles Using Acetylides and Sulfonyl Azides

Maria Elena Meza-Aviña; Mudita Kishor Patel; Cylivia B. Lee; Thomas J. Dietz; Mitchell P. Croatt

The reaction of acetylides with sulfonyl azides was found to selectively form 1,5-substituted sulfonyl triazoles. This reaction thus provides access to the regioisomeric product as compared to the popular copper-catalyzed azide-alkyne cycloaddition. The reaction is efficient and selective with a variety of alkyne sources and sulfonyl azides and can incorporate an additional electrophile to yield 1,4,5-trisubstituted sulfonyl triazoles.


Journal of Organic Chemistry | 2013

Mechanistic Study of the Biomimetic Synthesis of Flavonolignan Diastereoisomers in Milk Thistle

Hanan S. Althagafy; Maria Elena Meza-Aviña; Nicholas H. Oberlies; Mitchell P. Croatt

The mechanism for the biomimetic synthesis of flavonolignan diastereoisomers in milk thistle is proposed to proceed by single-electron oxidation of coniferyl alcohol, subsequent reaction with one of the oxygen atoms of taxifolins catechol moiety, and finally, further oxidation to form four of the major components of silymarin: silybin A, silybin B, isosilybin A, and isosilybin B. This mechanism is significantly different from a previously proposed process that involves the coupling of two independently formed radicals.


Angewandte Chemie | 2012

Reactions of Hypervalent Iodonium Alkynyl Triflates with Azides: Generation of Cyanocarbenes

I. F. Dempsey Hyatt; Mitchell P. Croatt

The creation of a fundamentally novel process can facilitate the development of shorter, and often more green, syntheses. Additionally, those novel processes which have the potential to reveal otherwise unimagined pathways to valuable reactive intermediates from simple, readily available substances warrant closer investigation. Towards these goals, we report herein a new method to generate cyanocarbene intermediates (2) from hypervalent iodonium alkynyl triflates (HIATs; 1) and azides, a reaction that converts an azide and two carbon atoms of an alkyne into dinitrogen and a cyanocarbene (Scheme 1). The value of this reactive intermediate, formed from readily available starting materials, is illustrated by three different carbene reactions including O H insertion, sulfoxide coordination, and cyclopropanation.


Bioorganic & Medicinal Chemistry | 2013

Semisynthesis, cytotoxicity, antiviral activity, and drug interaction liability of 7-O-methylated analogues of flavonolignans from milk thistle

Hanan S. Althagafy; Tyler N. Graf; Arlene A. Sy-Cordero; Brandon T. Gufford; Mary F. Paine; Jessica Wagoner; Stephen J. Polyak; Mitchell P. Croatt; Nicholas H. Oberlies

Silymarin, an extract of the seeds of milk thistle (Silybum marianum), is used as an herbal remedy, particularly for hepatoprotection. The main chemical constituents in silymarin are seven flavonolignans. Recent studies explored the non-selective methylation of one flavonolignan, silybin B, and then tested those analogues for cytotoxicity and inhibition of both cytochrome P450 (CYP) 2C9 activity in human liver microsomes and hepatitis C virus infection in a human hepatoma (Huh7.5.1) cell line. In general, enhanced bioactivity was observed with the analogues. To further probe the biological consequences of methylation of the seven major flavonolignans, a series of 7-O-methylflavonolignans were generated. Optimization of the reaction conditions permitted selective methylation at the phenol in the 7-position in the presence of each metabolites 4-5 other phenolic and/or alcoholic positions without the use of protecting groups. These 7-O-methylated analogues, in parallel with the corresponding parent compounds, were evaluated for cytotoxicity against Huh7.5.1 cells; in all cases the monomethylated analogues were more cytotoxic than the parent compounds. Moreover, parent compounds that were relatively non-toxic and inactive or weak inhibitors of hepatitis C virus infection had enhanced cytotoxicity and anti-HCV activity upon 7-O-methylation. Also, the compounds were tested for inhibition of major drug metabolizing enzymes (CYP2C9, CYP3A4/5, UDP-glucuronsyltransferases) in pooled human liver or intestinal microsomes. Methylation of flavonolignans differentially modified inhibitory potency, with compounds demonstrating both increased and decreased potency depending upon the compound tested and the enzyme system investigated. In total, these data indicated that monomethylation modulates the cytotoxic, antiviral, and drug interaction potential of silymarin flavonolignans.


Bioorganic & Medicinal Chemistry | 2015

Isolation, semisynthesis, covalent docking and transforming growth factor beta-activated kinase 1 (TAK1)-inhibitory activities of (5Z)-7-oxozeaenol analogues.

Lara Fakhouri; Tamam El-Elimat; Dow P. Hurst; Patricia H. Reggio; Cedric J. Pearce; Nicholas H. Oberlies; Mitchell P. Croatt

(5Z)-7-Oxozeanol and related analogues were isolated and screened to explore their activity as TAK1 inhibitors. Seven analogues were synthesized and more than a score of natural products isolated that examined the role that different areas of the molecule contribute to TAK1 inhibition. A novel nonaromatic difluoro-derivative was synthesized that had similar potency compared to the lead. This is the first example of a nonaromatic compound in this class to have TAK1 inhibition. Covalent docking for the isolated and synthesized analogues was carried out and found a strong correlation between the observed activities and the calculated binding.


Tetrahedron | 2015

Spiroscytalin, a new tetramic acid and other metabolites of mixed biogenesis from Scytalidium cuboideum

Arlene A. Sy-Cordero; Mario Figueroa; Huzefa A. Raja; Maria Elena Meza Aviña; Mitchell P. Croatt; Audrey F. Adcock; David J. Kroll; Mansukh C. Wani; Cedric J. Pearce; Nicholas H. Oberlies

Spiroscytalin (1), a new tetramic acid that possesses an uncommon spiro-ring fusion between a polyketide-derived octalin ring system and a 2,4-pyrrolidinedione, along with two known compounds, leporin B (2) and purpactin A (3), were isolated from a solid phase culture of the fungus Scytalidium cuboideum (MSX 68345). The molecular connectivity of 1-3 was determined using NMR spectroscopy and mass spectrometry. The relative configurations of 1 and 2 were determined by NOESY experiments. The absolute configuration of 1 was determined by electronic circular dichroism (ECD) via a combination of experimental measurements and computational calculations. While leporin B was known, it displayed activities that had not been reported previously, including cytotoxicity against three human tumor cell lines and antibacterial activity against Candida albicans and Staphylococcus aureus.


Organic Letters | 2013

Sequential Pd(0)-, Rh(I)-, and Ru(II)-Catalyzed Reactions in a Nine-Step Synthesis of Clinprost

Emma E. Nagy; I. F. Dempsey Hyatt; Kristen E. Gettys; Shawn T. Yeazell; Stephen K. Jr. Frempong; Mitchell P. Croatt

A step-economical synthesis of clinprost is reported that concludes with 3 different transition metal-catalyzed reactions: Pd-catalyzed decarboxylation with allylic rearrangement, Rh-catalyzed diene-ene [2+2+1] reaction, and Ru-catalyzed cross-metathesis reaction. The complexity bestowed to the molecule from these reactions converts a readily accessible ester to clinprost without using protecting groups in only 9 total steps.


Bioorganic & Medicinal Chemistry Letters | 2017

Structure-activity relationships of benzothiazole GPR35 antagonists

Manahil M. Abdalhameed; Pingwei Zhao; Dow P. Hurst; Patricia H. Reggio; Mary E. Abood; Mitchell P. Croatt

The first structure-activity relationships for a benzothiazole scaffold acting as an antagonist at GPR35 is presented. Analogues were designed based on a lead compound that was previously determined to have selective activity as a GPR35 antagonist. The synthetic route was modular in nature to independently explore the role of the middle and both ends of the scaffold. The activities of the analogues illustrate the importance of all three segments of the compound.


Bioorganic & Medicinal Chemistry | 2017

Chemoselective fluorination and chemoinformatic analysis of griseofulvin: Natural vs fluorinated fungal metabolites

Noemi D. Paguigan; Mohammed H. Al-Huniti; Huzefa A. Raja; Austin Czarnecki; Joanna E. Burdette; Mariana González-Medina; José L. Medina-Franco; Stephen J. Polyak; Cedric J. Pearce; Mitchell P. Croatt; Nicholas H. Oberlies

Griseofulvin is a fungal metabolite and antifungal drug used for the treatment of dermatophytosis in both humans and animals. Recently, griseofulvin and its analogues have attracted renewed attention due to reports of their potential anticancer effects. In this study griseofulvin (1) and related analogues (2-6, with 4 being new to literature) were isolated from Xylaria cubensis. Six fluorinated analogues (7-12) were synthesized, each in a single step using the isolated natural products and Selectflour, so as to examine the effects of fluorine incorporation on the bioactivities of this structural class. The isolated and synthesized compounds were screened for activity against a panel of cancer cell lines (MDA-MB-435, MDA-MB-231, OVCAR3, and Huh7.5.1) and for antifungal activity against Microsporum gypseum. A comparison of the chemical space occupied by the natural and fluorinated analogues was carried out by using principal component analysis, documenting that the isolated and fluorinated analogues occupy complementary regions of chemical space. However, the most active compounds, including two fluorinated derivatives, were centered around the chemical space that was occupied by the parent compound, griseofulvin, suggesting that modifications must preserve certain attributes of griseofulvin to conserve its activity.


Bioorganic & Medicinal Chemistry | 2017

Design, synthesis and biological evaluation of GPR55 agonists

Lara Fakhouri; Christopher D. Cook; Mohammed H. Al-Huniti; Linda Console-Bram; Dow P. Hurst; Michael B.S. Spano; Daniel J. Nasrallah; Marc G. Caron; Larry S. Barak; Patricia H. Reggio; Mary E. Abood; Mitchell P. Croatt

GPR55, a G protein-coupled receptor, is an attractive target to alleviate inflammatory and neuropathic pain and treat osteoporosis and cancer. Identifying a potent and selective ligand will aid to further establish the specific physiological roles and pharmacology of the receptor. Towards this goal, a targeted library of 22 compounds was synthesized in a modular fashion to obtain structure-activity relationship information. The general route consisted of coupling a variety of p-aminophenyl sulfonamides to isothiocyanates to form acylthioureas. For the synthesis of a known naphthyl ethyl alcohol motif, route modification led to a shorter and more efficient process. The 22 analogues were analyzed for their ability to serve as agonists at GPR55 and valuable information for both ends of the molecule was ascertained.

Collaboration


Dive into the Mitchell P. Croatt's collaboration.

Top Co-Authors

Avatar

I. F. Dempsey Hyatt

University of North Carolina at Greensboro

View shared research outputs
Top Co-Authors

Avatar

Nicholas H. Oberlies

University of North Carolina at Greensboro

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Maria Elena Meza-Aviña

University of North Carolina at Greensboro

View shared research outputs
Top Co-Authors

Avatar

Mohammed H. Al-Huniti

University of North Carolina at Greensboro

View shared research outputs
Top Co-Authors

Avatar

Patricia H. Reggio

University of North Carolina at Greensboro

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Daniel J. Nasrallah

University of North Carolina at Greensboro

View shared research outputs
Top Co-Authors

Avatar

Dow P. Hurst

University of North Carolina at Greensboro

View shared research outputs
Top Co-Authors

Avatar

Lara Fakhouri

University of North Carolina at Greensboro

View shared research outputs
Researchain Logo
Decentralizing Knowledge